Swissray to divest Empower in retooling

Article

Swissray International has released more details on its plans to reorganize the company (SCAN 2/18/98). In a move designed to focus the firm on digital imaging, the New York City-based digital radiography developer has signed a letter of intent to

Swissray International has released more details on its plans to reorganize the company (SCAN 2/18/98). In a move designed to focus the firm on digital imaging, the New York City-based digital radiography developer has signed a letter of intent to sell its Swissray Empower U.S. film and x-ray accessories division to distributor E.M. Parker, based in Wilmington, MA.

Terms of the transaction are still being negotiated, with a completion date expected during the current fiscal year, according to Swissray. Swissray had acquired the Empower business in April 1997 as part of the firm's attempt to offer a wide range of products and services to customers.

In other reorganization developments, the company's board of directors has decided to restructure its senior management as part of a plan to grow Swissray beyond a developmental-stage company, said Ruedi Laupper, chairman. A search is under way for a new CEO and CFO. Laupper, who previously also held the titles of president and CEO, retains primary responsibility for day-to-day operations.

In other company news, Swissray has sold another AddOn-Multi-System, to Dutchess Radiology Associates of Poughkeepsie, NY. Financial terms of the sale were not released.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.